The introduction of stab(e microbubb(e contrast asents and techno(osica( advances have recent(y made it feasib(e to perform quantitative measurements of microvascu(ar damase by myocardia( contrast echocardiosraphy (MCE). Qontrast ® is a new software system for such measurements. It inc (udes physio(osica( fi(ters, 8(oba( resca(e, resiona( resca(e, automatic myocardia( trackins, manua( ECG tri88er and parametric imasins. Qontrast ® was tested on 5 piss 8iven su(phur hexaf(uoride bubb(es (1 m(/min) and fluorescent microspheres (reference) after the induction of 50% and 100% stenosis of (eft anterior descendin8 coronary artery. The imase sequences were repeated four times usin8 different u(trasound (US) equipment. A close corre(ation was found between the ratio risk area/contro( area by microspheres and the equiva(ent ratio risk area/contro( area (SI×/~) by MCE, bein8 approximate(y 0.9 for any contrast moda(ity tested. Parametric MCE and SPECT were compared in 12 patients with recent myocardia( infarction, inc(udin8 119 sesments. Asreement amounted to 83% (kappa: 0.53 for peak SI and 0.55 for SI×/~). The sensitivity and specificity of peak SI for detectin8 abnorma( sesmenta( tracer uptake were 67% and 88%; the va(ues for SI×/~ were 70% and 87%. Parametric MCE is a promisin8 imasin8 technique for the assessment of myocardia( perfusion in patients with suspected or known coronary artery disease.
Introduction
Several recent studies have underlined the key role of microcircu[atory disorder in ischemic heart disease 1. The extent of microvascu[ar damage as assessed by myocardial contrast echocardiography (MCE) provides va[uab[e diagnostic and prognostic information for the management of patients with coronary artery disease (CAD) 1 13 This technique aUows assessment of the severity of microvas-S18 L. Agati et al. cutar damage in patients with acute myocardial infarction (AMI) after recanatization of the infarctrelated artery that is an independent predictor of left ventricutar remodeling. At the same time, dysfunctioning but stilt viable myocardial tissue after AMI that will benefit from revascutarization in terms of functional recovery and survival may be accurately assessed by MCE. Similar data may also be obtained by coronary angiography using TIMI grade and myocardial blush, but the quality of MCE images is much higher.
The information that MCE provides on myocardial tissue perfusion can also be used to assess myocardial salvage after reperfusion, coronary stenoses, and the presence of collateral circulation in the myocardial tissue area at risk 1 n.
The introduction of stable microbubbte contrast agents and technological advances have enabled the visualization of contrast in the coronary microvascutature even during low-energy realtime imaging, allowing simultaneous assessment of wall motion and myocardial perfusion 14 33 . By this method, microbubbte replenishment curves may be obtained that provide quantitative measurements of regional microcircutatory blood flow34, 35 .
In a recent study in which MCE quantitative findings were correlated to histological findings, a close correlation was found between MCE data and microvascutar density, capillary area, as well as collagen content 36.
Preliminary data showed that quantitative analysis of digital data provides more accurate diagnostic MCE information than does qualitative analysis of video signal intensity 37.
The objective of this paper is to present the results obtained with the new software system Qontrast ® 3s for quantitative analysis of real-time MCE images.
Q.ontrast ® software
The development of software for quantitative analysis of MCE images involved the solution of a number of problems. The main problem was the non-uniformity of myocardial contrast enhancement, which is due to the non-uniformity of bubble destruction in ultrasound fields. Additional issues were lateral field drop-out, partial apical bubble destruction, basal attenuation, and acoustic window dependence (Fig. I) .
To reduce the effects of these factors we introduced 3s (Fig. 2 • Global Rescale, which involves normalization of the signal observed as a function of the maximum signal intensity (SI) in each view; in other words, for any scan or view, the signal is rescaled with the maximum intensity reached in that view.
• Re~lional Rescale, which involves rescaling of the signal on the tissue with the maximum SI locally reached in the neighboring cavity sector (from wall to the axis) in that view, because energy is not uniform in the cavity, so the signal is related to the energy of bubble destruction.
• Automatic myocardial tracking1, which means that no manual adjustment (frame by frame) of the region of interest (ROI) is needed, because the system is able to automatically recognize the border of the myocardium. This feature resolves the issue of wall-motion artifacts 39 ( Fig. 3 ).
• Nlanual ECG tri~er, allowing manual removal of unwanted frames in which the quality of the bubble signal is reduced by a deep breath, probe motion or attenuation.
• Parametric ima~in~ which enables the calculation, and imaging on the entire scan plane, of the peak signal intensity (Sl), the refilling time (RT), the frequency of Sl rise (I~= IIRT) and the rate of Sl rise, or refilling slope, given by the product Sl×/~. This technique rapidly yields a perfusion map subdivided into segments with different colors corresponding to different Sl, following the SPECT color code (Fig. 4) . Parametric imaging is very simple to read, and refilling curves may be obtained in a few seconds point by point. In this way, quantitative MCE-derived parameters, evaluating myocardial blood volume (peak SI), myocardial blood flow velocity (/3) and myocardial blood flow (Six/3) may be calculated in each segmentat region. However, quantitative analysis is a very complex technique and not all issues have been resolved. Reproducibility is not fully satisfactory, as interindividua[ variabitity has been observed. This issue stems from the intrinsic nature of uttrasound imaging, which is highty dependent on operator skirt. Since bubbte resonance is strictty dependent on the insonating energy, the scan ptane with the best myocardia[ opacification shoutd be chosen carefutty. Operator-retated variabitity is a considerabte disadvantage that cannot be removed. Another issue is the lack of sufficient data at present to determine the sensitivity and specificity of the method.
Another probtem is the non-homogeneous contrast opacification. Atthough we woutd [ike to have a homogeneous medium, this is usuatty not the case. The 3D reconstruction in Fig. 5 shows that the brightness of the signa[ is different in different portions of the same areas of the septum. This is normat and is retated to non-homogeneous contrast enhancement. We tried to sotve this probtem by averaging signat intensity into the ROI.
Yet another probtem is the first frame after the flash. Quantitative parameters are strongty affected by residuat noise remaining in the myocardium after the ftash. Carefut attention has to be paid to reducing the gain or increasing the ftash duration so as to destroy art bubbtes. Neverthetess, there are some ptaces in the myocardium in which the constructed curve can be comptetety different depending on ROI tocation. For this reason we introduced the concept of the physiological filter, trying to avoid all the problems retated to the noise inside the myocardium after the flash.
Qontrast®: Experimental validation
The Qontrast ® software has been tested on 5 the same pig, different tow-MI contrast modatities were compared; fluorescent microspheres were used as a reference method. The animats were anesthetized by isofturane inhatation (Forene 1.5% in air/O2) and pentobarbitat infusion (5mr/h). Four catheters were inserted into the vessets of the animats: one into the femorat artery for the correction of reference brood samptes during fluorescent microsphere injections, one into the femorat vein for the infusion of pentobarbitat, one into the right externat jugutar vein for microbubbte infusion, and one into the [eft atrium for injection of fluorescent microspheres. The teft anterior descending coronary artery (LAD) was dissected free from surrounding tissue, a btood-ftow sensor was ptaced snugty around the vesset, and different degrees of stenosis were induced by a customdesigned inftatabte battoon. The animats were then given an infusion of sutphur hexaftuoride microbubbtes (SonoVue®, 1 mt/min) by the bascurating pump Viewject 41 . At steady state, 2 minutes after starting the infusion, 2 flash sequences were acquired manuatty at an intervat of at feast 25 s. Imaging sequences were obtained at basetine, at 50% stenosis and at 100% stenosis (i.e. occtusion). Ftuorescent microspheres were injected at each fever of stenosis as "gotd standard". The image sequences were repeated four times using different US equipment (i.e. Phitips Sonos 5500, Phitips HDI5000, Acuson Sequoia and Esaote Megas; see further detaits in Fig. 6 ). An exampte of how the parametric images fottow the flow in the area of interest directty is provided in Fig. 7 . A dose corretation was found between the ratio risk area/ controt area (MBF) by microspheres and the equivatent ratio risk area/controt area (S1×/3) by MCE, being approximatety 0.9 for any contrast modatity tested (Fig. 8) . In conctusion, experimentat data strongty support the ctinicat use of O.ontrast ®.
Qontrast®: clinical validation
We have generated pretiminary cUnicat data comparing parametric MCE and SPECT in 12 patients with recent myocardial, infarction. The cUnicat trial. was performed in comptiance with the tenets of the dectaration of Hetsinki; the trial, was approved by the tocat Ethics committee and art patients had given their written informed consent before undergoing echocardiography. Microvascutar damage was evatuated by real.-time MCE using continuous infusion of SonoVue by Viewject. At this time, SonoVue® is one of the most promising contrast agents when used with tow-MI techniques, for the fottowing characteristics: it is highty responsive to uttrasound energy, it can easity be destroyed at high energy, and the harmonic signal, at tow energy is strong. This contrast agent was administered as an infusion of 120-240mt/h (2-4mr/rain) using Sonos 5500 (Phitips) or CnTi (Esaote) and rear-time cotor and grayscate imaging (rt-MCE). Myocardial. perfusion was assessed using a 16-segment model. (4-2-chambers apical, views for rt-MCE, and horizontal, and vertical, tong axis views for SPECT). A total, of 119 segments were evatuated by both methods. For each LV segment, MCE-derived quantitative parameters (peak SI and Slxfi) were calculated. Receiver operating characteristics (ROC) curve analysis was employed to determine the optima[ cut-off values for both parameters to differentiate between normal and abnormal SPECT perfusion imaging. The best cut-off value was >14.3[/s for peak SI and >7.9[/s for Slxfi. Applying these values, the agreement between both techniques was 83% with a kappa value of 0.53 for peak SI and 83% with a kappa value of 0.55 for Slxfi. The sensitivity and specificity of peak SI to detect abnormal segmental tracer uptake at rest were 67% and 88%, respectively, whereas for Slxfi these were 70% and 87%, respectively. Thus, satisfactory agreement was found between these two perfusiona[ methods. Since this is one of the first studies 42 trying to compare quantitative MCE-derived parameters with SPECT perfusion imaging, we used the latter technique as a gold standard. However, SPECT may not be considered as a perfect reference method clue to the high incidence of false positive perfusion defects. An higher incidence of perfusion abnormalities was detected in segments with normal wail motion by SPECT as compared to quantitative MCE. Further, parametric MCE produces much more information than SPECT, providing data not only on myocardia[ brood votume but atso on myocardia[ blood flow velocity, whereas SPECT provides information on b[ood vo[ume on[y (Fig. 9) . The mean differences between these two perfusiona[ methods are summarized in Fig. 10 . Another important feature is the ability of parametric MCE to detect and analyze large-area perfusion defects (Fig. 11) 
